News‎ > ‎news2015‎ > ‎

Horizon 20:20 biomarker validation funding for SMEs

posted Nov 21, 2014, 6:03 AM by Stephanie Wallbank   [ updated Jun 21, 2016, 4:24 AM by Beck Lockwood ]

Horizon 20:20 biomarker validation funding for SMEs

The NIHR Diagnostic Evidence Co-operative Leeds is keen to develop Horizon 20:20 applications with UK and European small to medium sized enterprises (SMEs) with biomarker/diagnostic tests of potential benefit to patients and the NHS.

 For more information please contact us or refer to the following sites:

Comments